Atypical antipsychotic use in pregnancy: a retrospective review.
about
Mood stabilizers in pregnancy and lactationAntipsychotics in pregnancy and lactationAntipsychotic drugs in pregnancy: a review of their maternal and fetal effectsCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersNeurodevelopmental outcomes in infants exposed in utero to antipsychotics: a systematic review of published data.Pregnancy exposure to second-generation antipsychotics and the risk of gestational diabetes.Unplanned pregnancies leading to psychotropic exposure in women with mental illness - Findings from a perinatal psychiatry clinicPregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium.Atypical antipsychotic use and outcomes in an urban maternal mental health service.Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States.Depression and Anxiety During Pregnancy: Evaluating the Literature in Support of Clinical Risk-Benefit Decision-Making.Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study.Prevalence of atypical antipsychotic use in psychiatric outpatients: comparison of women of childbearing age with men.
P2860
Q26795394-C612AA83-7139-4FF8-AA14-016C492A08F0Q26795396-62D3C788-F3D1-4DBE-8329-31089325C718Q26824299-8608B08B-070C-4E93-B8FB-611657B57EECQ27009995-6201CFC6-7BA1-47C2-B2DE-50C5AD6B32B8Q31143455-58DE1E51-249F-4C60-9A34-CD0AF86B9EE2Q35238506-D92469EB-66CC-4B54-8498-1B70534E0EB5Q35919595-2074891F-8252-4144-9CCD-5907AB94BC77Q37011220-4DD19561-705A-419C-9963-4E839016F66FQ37026000-42195F40-7CD8-4A33-AC42-785B943359E2Q38241431-01DE6D50-9CD6-4488-A909-FFB623727EDBQ38718876-CADEBA22-C80B-47E0-ABAD-259FAED06489Q38724641-0A7E7567-951C-4809-B8E2-949F95F361B9Q38811512-F0B26229-7BAD-4BF8-BCD2-6B3D071717D2Q41433722-A764BD4C-B4F1-437F-AC0A-11D653B32FB3Q44142664-CC78EB22-6395-4A97-8646-0E1BC9F3AACFQ44677911-60E67611-3931-45F7-96FE-F5E7F64E760FQ48205231-0EB4704E-9505-4B5C-9793-23FB6247D1A7
P2860
Atypical antipsychotic use in pregnancy: a retrospective review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atypical antipsychotic use in pregnancy: a retrospective review.
@en
Atypical antipsychotic use in pregnancy: a retrospective review.
@nl
type
label
Atypical antipsychotic use in pregnancy: a retrospective review.
@en
Atypical antipsychotic use in pregnancy: a retrospective review.
@nl
prefLabel
Atypical antipsychotic use in pregnancy: a retrospective review.
@en
Atypical antipsychotic use in pregnancy: a retrospective review.
@nl
P1476
Atypical antipsychotic use in pregnancy: a retrospective review.
@en
P2093
Christina L Wichman
P2888
P356
10.1007/S00737-008-0044-3
P577
2009-01-10T00:00:00Z